According to Stratistics MRC, the Global Protein Labeling market is expected to grow from $1,133.48 million in 2016 to reach $2030.65 million by 2022 with a CAGR of 10.2%. Increasing health care awareness, growing investments on research & development, and introduction of innovative products are the factors propelling the market growth. In addition, growing proteomics research is bolstering the market growth. However, limited number of skilled professionals, high costs of products is the restrains hindering the market growth.

Among all product segments, reagents is anticipated to dominate the market over the forecast period. This dominance is accounted for growing demand for peptide binding agents and increasing research and development activities. By application, immunological techniques segment represents largest segment with a higher market share. North America is anticipated to hold the largest share in global protein labeling market due to increasing demand from U.S. and Asia Pacific is likely to grow at a moderate rate during the forecast period.

Some of the key players in global protein labeling market include Agilent Technologies Inc., Bio-Rad Laboratories, Eurogentec S.A, F. Hoffman-La Roche AG, General Electric Company, Kaneka Corporation, Kirkegaard & Perry Laboratories (KPL), Li-Cor, Inc., Merck KGaA (Germany), New England Biolabs, Perkinelmer, Inc., Promega Corporation, Qiagen N.V., Seracare Life Sciences, Inc., and Thermo Fisher Scientific, Inc.

Products Covered:

  • Services
  • Kits
  • Reagents
  • ·Probes/Tags
  • ·Enzymes
  • ·Proteins
  • ·Monoclonal Antibodies
  • ·Other Reagents

Labeling Methods Covered:

  • Bioorthogonal Labeling
  • In Vivo Labeling
  • ·Radioactive Labeling
  • ·Photoreactive Labeling
  • In Vitro Labeling
  • ·Co-Translational Labeling
  • ·Enzymatic Labeling
  • ·Nanoparticle Labeling
  • ·Dye-Based Labeling
  • ·Site-Specific Labeling

Applications Covered:

  • Fluorescence Microscopy
  • Mass Spectrometry
  • Immunological Techniques
  • Protein Microarrays
  • Cell-Based Assays

End Users Covered:

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Other End Users

Regions Covered:

  • North America
  • ·US
  • ·Canada
  • ·Mexico
  • Europe
  • ·Germany
  • ·France
  • ·Italy
  • ·UK
  • ·Spain
  • ·Rest of Europe
  • Asia Pacific
  • ·Japan
  • ·China
  • ·India
  • ·Australia
  • ·New Zealand
  • ·Rest of Asia Pacific
  • Rest of the World
  • ·Middle East
  • ·Brazil
  • ·Argentina
  • ·South Africa
  • ·Egypt

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements